ERBB2 and neoplasm: It could be hypothesized that the infiltrated immune cells present in the TIME of the HER2 positive tumors are activated upon anti-HER2 treatment to trigger anti-tumor immunity, especially since we found lower expression of inhibitory signals associated to immune exhaustion.